P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL

por Maria Ribera, Josep, Morgades, Mireia, García-Calduch, Olga, Sirvent, Maialen, Buendía Ureña, Buenaventura, Cervera, Marta, Luzardo, Hugo, Hernández Rivas, Jesus, Sitges Arriaga, Marta, Garcia Cadenas, Irene, Abrisquet Acosta, Pablo, Montesinos, Pau, Bastos Oreiro, Mariana, Queipo de Llano, María-Paz, Bravo, Pilar, Torrent, Anna, Puente, Maria Pilar Herrera, Garcia-Guiñon, Antonio, Vall-Llovera Calmet, Ferran, Serrano, Josefina, Terol, Maria J, Burgues, Juan Miguel Bergua, García-Noblejas, Ana, Barrenetxea, Cristina, Llorente, Laura, García-Belmonte, Daniel, Gimeno, Eva, Cladera, Antonia, Mercadal Vilchez, Santiago, Manuel Sancho, Juan
Publicado 2023